We are excited to announce the CNS Diseases World Summit, to be held on September 12-15, 2016 in Boston, MA. This meeting provides an interactive learning and relationship-building forum for all players in the CNS field. Colleagues from industry, academia, government agencies, and financing bodies will gather at the interface of research, partnerships, funding, and commercialization to find ways to move forward in a field that has been troubled with clinical failures.
The program will provide a comprehensive look at the current state of CNS, from research to commercialization. Above all, this event will provide networking opportunities in an intimate and accessible environment.
The CNS Diseases World Summit consists of two, back-to-back conferences:

10th Neurodegenerative Conditions Research & Development
Sessions include:
I. Neuroinflammation Across CNS Disorders
II. Advances in Parkinson’s Disease Research & Therapeutics
III. Advances in Genetics and Systems Biology
IV. Biomarkers: Translation from Discovery to Clinical
V. Novel Therapeutics & Approaches in Alzheimer’s Disease
VI. Rare and Orphan CNS Disorders
9th CNS Partnering & Deal-Making
Sessions include:
I. CNS: Present and Future
II. Partnering & Licensing in CNS
Panels include:
I. Is Now the Time for Neurodegeneration R&D?
II. What Sells Big Pharma in CNS
III. Partnering with Patient Groups to Advance Research
IV. Regulatory Considerations for Orphan Drug Products
V. CNS Perspectives: Venture Capital and Public Markets

A summit pass will get you access to both conferences. We invite you to join us as we connect, build relationships, and seek new ways forward into the future of CNS research and development.

We hope to see you there!